Catechol-O-methyl Transferase and Expression of Schizophrenia in 73 Adults with 22q11 Deletion Syndrome

Biological Psychiatry

Volumn 61, Issue 10, 2007, Pages 1135-1140

  Bassett, Anne S ^a,b,c   Caluseriu, Oana ^a   Weksberg, Rosanna ^a   Young, Donald A ^a,b,d   Chow, Eva W C ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

22q11 deletion syndrome; Catechol O methyl transferase; genetic risk; impulsivity; schizophrenia; velocardiofacial syndrome

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; BRAIN FUNCTION; CHROMOSOME 22Q; CHROMOSOME DELETION; COGNITION; COMMUNICATION SKILL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HEMIZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL INTERACTION;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; AROUSAL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; FRONTAL LOBE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; MALE; METHIONINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SYNDROME; VALINE;

EID: 34247636739     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.07.038     Document Type: Article

References (45)

1. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7 (2002) 405-411
2. Baker K., Baldeweg T., Sivagnanasundaram S., Scambler P., and Skuse D. COMT Val(108/158)Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry 58 (2005) 23-31
3. Bassett A.S., and Chow E.W.C. 22q11 deletion syndrome: A genetic subtype of schizophrenia. Biol Psychiatry 46 (1999) 882-891
4. Bassett A.S., Chow E.W., AbdelMalik P., Gheorghiu M., Husted J., and Weksberg R. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 160 (2003) 1580-1586
5. Bassett A.S., Chow E.W.C., Husted J., Weksberg R., Caluseriu O., Webb G.D., et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A 138 (2005) 307-313
6. Bassett A.S., Hodgkinson K., Chow E.W.C., Correia S., Scutt L.E., and Weksberg R. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 81 (1998) 328-337
7. Bearden C.E., Jawad A.F., Lynch D.R., Monterossso J.R., Sokol S., McDonald-McGinn D.M., et al. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 deletion syndrome. Child Neuropsychol 11 (2005) 109-117
8. Bearden C.E., Jawad A.F., Lynch D.R., Sokol S., Kanes S.J., McDonald-McGinn D.M., et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry 161 (2004) 1700-1702
9. Bilder R.M., Volavka J., Lachman H.M., and Grace A.A. The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29 (2004) 1943-1961
10. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75 (2004) 807-821
11. Chow E.W., Watson M., Young D.A., and Bassett A.S. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res 87 (2006) 270-278
12. Doty R.L., Shaman P., and Dann M. Development of the University of Pennsylvania Smell Identification Test: A standardized microencapsulated test of olfactory function. Physiol Behav 32 (1984) 489-502
13. Driscoll D.A., Salvin J., Sellinger B., Budarf M.L., McDonald-McGinn D.M., Zackai E.H., et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: Implications for genetic counselling and prenatal diagnosis. J Med Genet 30 (1993) 813-817
14. Dunham I., Collins J., Wadey R., and Scambler P. Possible role for COMT in psychosis associated with velo-cardio-facial syndrome. Lancet 340 (1992) 1361-1362
15. Egan M.F., Goldberg T.E., Kolachana B., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 6917-6922
16. Feinstein C., Eliez S., Blasey C., and Reiss A.L. Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: Usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 51 (2002) 312-318
17. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV) (1997), American Psychiatric Association, Washington, DC
18. Glatt S.J., Faraone S.V., and Tsuang M.T. Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family-based studies. Am J Psychiatry 160 (2003) 469-476
19. Goldman-Rakic P.S., Muly III E.C., and Williams G.V. D(1) receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31 (2000) 295-301
20. Gothelf D., Eliez S., Thompson T., Hinard C., Penniman L., Feinstein C., et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 8 (2005) 1500-1502
21. Graf W.D., Unis A.S., Yates C.M., Sulzbacher S., Dinulos M.B., Jack R.M., et al. Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism. Neurology 57 (2001) 410-416
22. Heaton R.K., Chelune G.J., Talley J., Kay G.G., and Curtiss G. Wisconsin Card Sorting Test manual, revised and expanded (1993), Psychological Assessment Resources, Odessa, FL
23. Horowitz A., Shifman S., Rivlin N., Pisante A., and Darvasi A. A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr Res 73 (2005) 263-267
24. Karayiorgou M., Morris M.A., Morrow B., Shprintzen R.J., Goldberg R., Borrow J., et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A 92 (1995) 7612-7616
25. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13 (1987) 261-275
26. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
27. Lambe E.K., Krimer L.S., and Goldman-Rakic P.S. Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J Neurosci 20 (2000) 8780-8787
28. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, Part II: Schizophrenia. Am J Hum Genet 73 (2003) 34-48
29. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S., and Bark N. Psychopathology of schizophrenia: Initial validation of a 5-factor model. Psychopathology 28 (1995) 22-31
30. Maynard T.M., Haskell G.T., Peters A.Z., Sikich L., Liberman J.A., and LaMantia A.-S. A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc Natl Acad Sci U S A 100 (2003) 14433-14438
31. Meyer-Lindenberg A., Kohn P.D., Kolachana B., Kippenhan S., McInerney-Leo A., Nussbaum R., et al. Midbrain dopamine and prefrontal function in humans: Interaction and modulation by COMT genotype. Nat Neurosci 8 (2005) 594-596
32. Moore J.H. A global view of epistasis. Nat Genet 37 (2005) 13-14
33. Munafo M.R., Bowes L., Clark T.G., and Flint J. Lack of association of the COMT (Val(158/108) Met) gene and schizophrenia: A meta-analysis of case-control studies. Mol Psychiatry 10 (2005) 765-770
34. Murphy K.C., Jones L.A., and Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56 (1999) 940-945
35. Reitan R., and Wolfson D. The Halstead-Reitan Neuropsychological Test Battery (1985), Neuropsychology Press, Tuscon, AZ
36. Russell T.A. An Examination of "Theory of Mind" in people with schizophrenia and related executive tasks (1996), University College, London
37. Silverstein A.B. Two- and four- subtest short forms of the Wechsler Adult Intelligence Scale-Revised. J Consult Clin Psychol 50 (1982) 415-418
38. Sparrow S.S., Balla D.A., and Cicchetti D.V. Vineland Adaptive Behaviour Scales (1984), American Guidance Service, Circle Pines, MN
39. Spitzer R.L., Williams J.B.W., Gibbon M., and First M.B. Structured Clinical Interview for DSM-III-R, Patient Edition (1990), American Psychiatric Press, Washington, DC
40. Spreen D., and Benton A.L. Neurosensory Center Comprehensive Examination for Aphasia (1969), Neuropsychology Laboratory, Victoria, Canada
41. Strous R.D., Lapidus R., Viglin D., Kotler M., and Lachman H.M. Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia. Neurosci Lett 393 (2006) 170-173
42. Wechsler D. Wechsler Adult Intelligence Scale-Revised (1981), Psychological Corporation, San Antonio, TX
43. Wechsler D. Wechsler Adult Intelligence Scale. Third Edition (1997), Psychological Corporation, San Antonio, TX
44. Wechsler D. Wechsler Abbreviated Scale of Intelligence (WASI) (1999), Harcourt Brace Jovanovich, San Antonio, TX
45. Wiehahn G.J., Bosch G.P., du Preez R.R., Pretorius H.W., Karayiorgou M., and Roos J.L. Assessment of the frequency of the 22q11 deletion in Afrikaner schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 129 (2004) 20-22